US 11564997
Materials and methods for treatment of friedreich ataxia and other related disorders
granted A61KA61K35/30A61K48/005
Quick answer
US patent 11564997 (Materials and methods for treatment of friedreich ataxia and other related disorders) held by CRISPR THERAPEUTICS AG expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K35/30, A61K48/005, A61K48/0058, A61K48/0066